In this study, we developed and describe a novel method to knock down the angiogenic receptor of VEGF, VEGF receptor 2 (VEGFR2), specifically in retinal endothelial cells in the rat OIR model that represents human ROP [12]. This evidence concerns the gene VEGFA and retinopathy of prematurity.